Literature DB >> 4380598

Comparison of some properties of pronethalol and propranolol.

J W Black, W A Duncan, R G Shanks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 4380598      PMCID: PMC1510623          DOI: 10.1111/j.1476-5381.1965.tb01782.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  27 in total

1.  THE EFFECT OF AN ADRENERGIC BETA-RECEPTOR ANTAGONIST ON THE CARDIOVASCULAR SYSTEM OF THE DOG.

Authors:  D E DONALD; J KVALE; J T SHEPHERD
Journal:  J Pharmacol Exp Ther       Date:  1964-03       Impact factor: 4.030

2.  THE CHRONOTROPIC AND VAGAL-BLOCKING ACTIONS OF NAPHTHYLISOPROTERENOL STUDIED BY DIRECT PERFUSION OF THE SINUS NODE.

Authors:  T N JAMES; R A NADEAU
Journal:  J Pharmacol Exp Ther       Date:  1964-03       Impact factor: 4.030

3.  HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.

Authors:  J COHEN; H EFFAT; J F GOODWIN; C M OAKLEY; R E STEINER
Journal:  Br Heart J       Date:  1964-01

4.  THE ADRENERGIC RECEPTIVE MECHANISM OF THE RAT UTERUS.

Authors:  B LEVY; S TOZZI
Journal:  J Pharmacol Exp Ther       Date:  1963-11       Impact factor: 4.030

5.  THE HAEMODYNAMIC EFFECTS OF BETA-SYMPATHETIC BLOCKADE.

Authors:  D A CHAMBERLAIN; J HOWARD
Journal:  Br Heart J       Date:  1964-03

6.  CARCINOGENIC ACTION OF PRONETHALOL.

Authors:  G E PAGET
Journal:  Br Med J       Date:  1963-11-16

7.  BETA-ADRENERGIC RECEPTOR BLOCKADE IN CARDIAC ARRHYTHMIAS.

Authors:  J P STOCK; N DALE
Journal:  Br Med J       Date:  1963-11-16

8.  Prevention of arrhythmias due to cardiac glycosides by block of sympathetic beta receptors.

Authors:  E M WILLIAMS; A SEKIYA
Journal:  Lancet       Date:  1963-02-23       Impact factor: 79.321

9.  Effect of phenoxybenzamine on vagal inhibition of the heart.

Authors:  B G BENFEY
Journal:  Can J Biochem Physiol       Date:  1962-10

10.  Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118).

Authors:  F B ORLANS; K F FINGER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1960-02       Impact factor: 4.030

View more
  84 in total

1.  Bufuralol, a new beta-adrenoceptor blocking agent.

Authors:  G A Fothergill; R J Francis; T C Hamilton; J M Osbond; M W Parkes
Journal:  Experientia       Date:  1975-11-15

2.  THE USE OF NON-INVASIVE TECHNIQUES IN MANAGEMENT OF PATIENTS WITH ANGINA PECTORIS ON ORAL PROPRANOLOL.

Authors:  William H. Frishman; Charles Smithen; Paul Kligfield; Thomas Killip
Journal:  Cardiovasc Dis       Date:  1974

3.  Improved fluorimetric assay of plasma propranolol.

Authors:  L Offerhaus; J R van der Vecht
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

4.  Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer-Aided Drug Repurposing.

Authors:  Tudor I Oprea; Sonny Kim Nielsen; Oleg Ursu; Jeremy J Yang; Olivier Taboureau; Stephen L Mathias; Lrene Kouskoumvekaki; Larry A Sklar; Cristian G Bologa
Journal:  Mol Inform       Date:  2011-03-14       Impact factor: 3.353

5.  Some effects of Kö 1313 in animals and man.

Authors:  J M Ekue; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

6.  Ro 3-4787, a new β-adrenoceptor blocking agent: Studies in normal volunteers.

Authors:  J R Kilborn; P Turner
Journal:  Br J Clin Pharmacol       Date:  1974-04       Impact factor: 4.335

7.  The mechanism of the cardio-acceleration elicited by electrical stimulation of the parahypoglossal area in the cat.

Authors:  F R Calaresu; J L Henry
Journal:  J Physiol       Date:  1970-09       Impact factor: 5.182

8.  The impact of therapeutic reference pricing on innovation in cardiovascular medicine.

Authors:  Desmond Sheridan; Jim Attridge
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

9.  In vivo and in vitro studies of bacterial endotoxin-membrane interactions and the effects of membrane-active agents.

Authors:  M E Garnett; D V Godin; J M Tuchek
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

10.  Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog.

Authors:  T Ishizaki; K Tawara
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.